A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Saved in:
Bibliographic Details
Main Authors: Hajda, Jacek (Author) , Lehmann, Monika (Author) , Kieser, Meinhard (Author) , Jäger, Dirk (Author) , Schöning, Tilman (Author) , Sedlaczek, Oliver (Author) , Stenzinger, Albrecht (Author) , Halama, Niels (Author) , Daniel, Volker (Author) , Engeland, Christine Elisabeth (Author) , Springfeld, Christoph (Author)
Format: Article (Journal) Book/Monograph
Language:English
Published: London; Berlin; Heidelberg BioMed Central; Springer 2017
DOI:10.1186/s12885-017-3604-y
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-017-3604-y
Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-234846
Get full text
Author Notes:Jacek Hajda; Monika Lehmann; Ottheinz Krebs; Meinhard Kieser; Karsten Geletneky; Dirk Jäger; Michael Dahm; Bernard Huber; Tilman Schöning; Oliver Sedlaczek; Albrecht Stenzinger; Niels Halama; Volker Daniel; Barbara Leuchs; Assia Angelova; Jean Rommelaere; Christine E. Engeland; Christoph Springfeld; Guy Ungerechts
Description
Item Description:Aus: BMC Cancer, 17 (2017), Nr. 576. pp. 1-11. ISSN 1471-2407
Physical Description:Online Resource
DOI:10.1186/s12885-017-3604-y